ask our doctors

Cardioembolic Stroke

Get the facts on Cardioembolic Stroke treatment, diagnosis, staging, causes, types, symptoms. Information and current news about clinical trials and trial-related data, Cardioembolic Stroke prevention, screening, research, statistics and other Cardioembolic Stroke related topics. We answer all your qestions about Cardioembolic Stroke.

Question: would you treat atrial fibrillation if a patient is on dual chamber pace maker? is there a need to start anticoagulation in this case? what is the risk of cardioembolic stroke in these patients?

Answer: Anticoagulation is very important. There are other medications besides coumadin. But Even with a dual pacer, a person can still go into afib, or have rhythms that can cause an embolic event. I do not know what the actual statistics are, but I do know that it is a standard to place a person on anticoagulation with afib. (right now I have a pt on a dual pacer, and she STILL has persistent afib without even feeling it. ) a pacer can speed up to help bring the heart rate down, it can pace the heart to hopefully assume a normalized beat, and it can shock a person out of a dangerous rytymn. But in the meantime, if the person goes into afib, the risks for clots getting thrown off of a valve increase tremendously.


Cardioembolic Stroke News

Aspirin, Plavix Not Good Stroke Prevention Combo

MedPage Today
Inclusion criteria included having had an MRI-verified lacunar stroke within 180 days. Patients with cortical stroke, cardioembolic disease, or carotid stenosis were excluded from the trial. Baseline characteristics were similar between both arms.
 

Silent Atrial Fibrillation Increases Stroke Risk

Medscape
Although it "strains logic" that a 6-minute episode of AF would cause a cardioembolic stroke, patients with brief episodes of AF are likely to have longer episodes that lead to cardioembolic events, he writes. To support causation, the AF should ...
 

Aspirin as Effective as Warfarin in Heart Failure: WARCEF

Medscape
Warfarin reduced ischemic stroke risk throughout the trial, but was associated with more major hemorrhage; intracerebral and intracranial hemorrhage were similar between groups. "In terms of clinical implications, given no overall benefit of warfarin ...